This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Actress Christina Hendricks Urges Women To Join Her In The Final Weeks Of The LATISSE® Wishes Challenge To Increase Money Raised For The Make-A-Wish Foundation® From $390,000 To Campaign Goal Of $500,000

IRVINE, Calif., Nov. 9, 2011 /PRNewswire/ -- Emmy®-nominated actress Christina Hendricks, in partnership with Allergan, Inc. (NYSE: AGN), the maker of LATISSE® (bimatoprost ophthalmic solution) 0.03% is calling on women to help her in a final push to raise $500,000 for the Make-A-Wish Foundation by November 30 through the LATISSE® Wishes Challenge – a campaign inspired by the tradition of blowing on an eyelash to make wishes come true. Since its launch in June 2011, participants in the LATISSE® Wishes Challenge have helped to raise more than $390,000 for the Make-A-Wish Foundation, but $110,000 is still needed to meet the campaign goal and help grant a wish in every Make-A-Wish® chapter across the country.  




With just weeks until the campaign's close, Hendricks, a LATISSE® user, is urging women to help by donating a minimum of $20 on by November 30. As a thank you, the first 10,000 participants making the minimum $20 donation will receive a free trial certificate for a one month's supply of LATISSE® – the first and only prescription treatment approved by the U.S. Food and Drug Administration (FDA) to grow lashes longer, fuller and darker for those with inadequate or not enough lashes (eyelash hypotrichosis) – to take to a doctor to determine if LATISSE® is right for them. Campaign participants who invite two friends to support the campaign will also receive a $20 rebate off their next purchase of LATISSE®.

"Every donation counts towards making a child's wish come true," said Hendricks. "I had the honor of helping to grant a wish for 17-year-old David who wanted to attend the Primetime Emmy® Awards. It was a pleasure to escort David and his family on the Red Carpet at this year's awards and to know that David enjoyed 'star treatment' that day. There are so many other wishes to grant to courageous children like David, and I hope women will join me in supporting the Make-A-Wish Foundation by participating in the LATISSE® Wishes Challenge.

"I also hope that women take advantage of the opportunity to receive the free trial certificate for LATISSE®. My lashes have always been thin and light in color, and over time, I know they will continue to thin out even more. I talked to my doctor about LATISSE® and have been using it nightly for 16 weeks now to grow my lashes longer, fuller and darker. I am thrilled by my lash results and encourage women interested in LATISSE® to visit to support the Make-A-Wish Foundation and ask their doctor if LATISSE® is right for them."  

Women can join the LATISSE® Wishes Challenge by November 30 to support the Make-A-Wish Foundation, learn more about LATISSE® and see the results of Hendricks' full 16-week use of LATISSE® at Important safety information is presented below and can be found on Women can also stay connected to the LATISSE® Wishes Challenge on Twitter via @WishesChallenge and on Facebook.


LATISSE® (bimatoprost ophthalmic solution) 0.03% is a prescription treatment for hypotrichosis used to grow eyelashes longer, fuller and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. The once-daily prescription treatment is applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. While individual results may vary, LATISSE® users may begin to notice longer lashes in about one month and experience full results in four months. If use of LATISSE® is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of several weeks to months (average eyelash hair cycle).

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs